CA
NZ
UK
AU
IND
US
Onconetix, Inc. filed a current report on Form 8-K on November 6, 2026, disclosing that the company and its counterparties executed the First Amendment to the Share Exchange Agreement with Realbotix on November 4, 2026, modifying several key terms of the transaction originally signed …
Sylvamo Corporation filed a Form 8-K on November 6, 2026, disclosing that it has entered into a put option agreement with Midas Atlantic Partners, in partnership with The Najafi Companies, for a binding offer to acquire the company's Europe business.
Coca-Cola Europacific Partners plc filed a Form 6-K on November 6, 2026, announcing the appointment of Sean Summers as an Independent Non-executive Director, effective December 1, 2026.
Starry Sea Acquisition Corp filed a current report on November 6, 2026, disclosing that on November 3, 2026, it deposited $60,000 into its trust account to extend its business combination deadline by one month, from November 7, 2026 to December 7, 2026.
Onconetix, Inc. filed a current report on Form 8-K on November 6, 2026, disclosing that on November 4, 2026, it entered into the First Amendment to its Share Exchange Agreement with Realbotix Corp., Simulacra Corporation, and Realbotix, LLC.
X Financial filed a Form 6-K on November 6, 2026, disclosing that its board of directors received a preliminary non-binding proposal from Mangrove Coast Investment Limited to acquire all outstanding ordinary shares not already owned by Mangrove at US$1.005 per ordinary share, or US$6.03 …
Inflection Point Acquisition Corp. VII filed a Form 425 on November 6, 2026, disclosing that the SEC declared effective the Form S-4 registration statement for its proposed business combination with Elroy Air, Inc., with a shareholder vote scheduled for November 25, 2026.
Wang Yanjun, Chief Compliance Officer and General Counsel of Sea Ltd, filed a Form 4 on November 6, 2026, disclosing the sale of 1,600 Class A ordinary shares across ten transactions on November 4 and 5, 2026, executed through a BVI entity under a …
Zhao Feng, President of Garena at Sea Ltd, filed a Form 4 on November 6, 2026, disclosing the sale of 30,000 Class A ordinary shares on November 4, 2026, through a BVI entity he controls.
Gyre Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the fiscal quarter and nine months ended September 30, 2026, disclosing a net loss attributable to common stockholders of $28.9 million for the nine-month period.
Please wait processing your request...